To the best of our knowledge, this is an extremely rare case report that describes the simultaneous development of pneumonitis and DM after 8 cycles treatment with PD-L1 inhibitor (durvalumab) in an advanced SCLC patient. Here, CD274 is linked to small cell lung carcinoma.